Federica Giordani

6PUBLICATIONS
27CO-AUTHORS
Major global burdens of diseaseBiomolecular modelling and designAnimal growth and developmentTraditional Chinese medicine and treatmentsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 09, 2021
Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole.

Pieter C Steketee, Federica Giordani, Isabel M Vincent

|Aug 27, 2021
Truncated S-MGBs: towards a parasite-specific and low aggregation chemotype.

Daniel P Brooke, Leah M C McGee, Federica Giordani

|Nov 03, 2020
Veterinary trypanocidal benzoxaboroles are peptidase-activated prodrugs.

Federica Giordani, Daniel Paape, Isabel M Vincent

|Feb 26, 2020
New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story.

Emily A Dickie, Federica Giordani, Matthew K Gould

|Sep 26, 2018
The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing.

Daniela Begolo, Isabel M Vincent, Federica Giordani

|May 15, 2018
Benzoxaborole treatment perturbs S-adenosyl-L-methionine metabolism in Trypanosoma brucei.

Pieter C Steketee, Isabel M Vincent, Fiona Achcar

Pageof 1

Frequent Collaborators

3 joint publications

Isabel M Vincent

2 joint publications

Pieter C Steketee

2 joint publications

Michael J Witty

2 joint publications

Liam J Morrison